Ds. Choi et al., 5-HT2B RECEPTOR-MEDIATED SEROTONIN MORPHOGENETIC FUNCTIONS IN MOUSE CRANIAL NEURAL CREST AND MYOCARDIAL-CELLS, Development, 124(9), 1997, pp. 1745-1755
During embryogenesis, serotonin has been reported to be involved in cr
aniofacial and cardiovascular morphogenesis. The detailed molecular me
chanisms underlying these functions, however remain unknown, From mous
e and human species, we have recently reported the cloning of 5-HT2B r
eceptors which share signal transduction pathways with other 5-HT2 rec
eptor subtypes (5-HT2A and 5-HT2C). In addition to phospholipase C sti
mulation, it appears that these three subtypes of receptor transduce a
common serotonin-induced mitogenic activity, which could be important
for cell differentiation and proliferation, We have first investigate
d the expression of 5-HT2 receptor mRNAs in the mouse embryo, Interest
ingly, a peak of 5-HT2B receptor mRNA expression was detected 8-9 days
postcoitum, whereas there was only low level 5-HT2A and no 5-HT2C rec
eptor mRNA expression at this stage, Expression of this receptor was c
onfirmed by binding assays using a 5-HT2-specific ligand which reveale
d a peak of binding to membrane preparations from 9 days postcoitum em
bryos, In addition, whole mount in situ hybridisation and immunohistoc
hemistry on similar stage embryos detected 5-HT2B expression in neural
crest cells, heart myocardium and somites; The requirement for functi
onal 5-HT2B receptors between 8 and 9 days postcoitum is supported by
culture of embryos exposed to 5-HT2-specific ligands; 5-HT2B high-affi
nity antagonist such as ritanserin, induced morphological defects in t
he cephalic region, heart and neural tube, These antagonistic treatmen
ts interfere with cranial neural crest cell migration, induce their ap
optosis, and are responsible for abnormal sarcomeric organisation of t
he subepicardial layer and for the absence of the trabecular cell laye
r in the ventricular myocardium, This report indicates for the first t
ime that 5-HT2B receptors are actively mediating the action of seroton
in on embryonic morphogenesis, probably by preventing the differentiat
ion of cranial neural crest cells and myocardial precursor cells.